Focus Rheums| Dr. Jekyll or Mr. Hyde? (video)

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Research Into Causes of Systemic Vasculitis May Lead to Targeted Treatments Say Rheumatologists at the 2013 ACR/ARHP Annual Meeting

  |  Issue: March 2014  |  

“The pathogenesis of vasculitides includes multiple factors,” she said. “Genetic predisposition is very important, as well as environmental factors. We also should not neglect the role of the microenvironment where inflammation starts, which sets the stage for a suitable battle field.”

Mary Beth Nierengarten is a freelance medical journalist based in St. Paul, Minn.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367:214-223.

Related Articles

    Updates on Giant Cell Arteritis

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…